Not Signed In - First Actemra Multinational Phase III Trial Demonstrates Significant Improvement In Signs And Symptoms Of Rheumatoid Arthritis
Mon, 29 Jan 2007 08:00 AM EST
... Roche announced today that 'OPTION'1, the first multinational phase III study of Actemra (tocilizumab) outside of Japan, successfully met its primary endpoint in the group of patients with moderate to severe rheumatoid arthritis (RA) who had an inadequate response to methotrexate. [click link for full article] ...
Related Topics
- Rheumatoid Arthritis
- Arthritis
- Clinical Trials
- Juvenile Rheumatoid Arthritis
- Rheumatoid Factor
- Rituximab
- The signs and symptoms related to the central nervous system may be irreversible if treatment is not begun within 6 months of when these symptoms begin.
- Ovarian Cancer
- Arthritis, Rheumatoid
- Antithrombin III
- Signs And Symptoms, Respiratory
- Osteoarthritis
- Adalimumab
- Pregnancy
- Septic Arthritis
- Infliximab
- Reactive Arthritis
- Preeclampsia
- Permanent and significant neurologic problems
- Familial Dysautonomia
email this page
print this page
bookmark this page
feedback on this page
